Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1-2 N0 M0 renal cell carcinoma

被引:31
|
作者
Marchioni, Michele [1 ,2 ]
Martel, Tristan [1 ,3 ]
Bandini, Marco [1 ,4 ]
Pompe, Raisa S. [1 ,5 ]
Tian, Zhe [1 ]
Kapoor, Anil [6 ]
Cindolo, Luca [7 ]
Autorino, Riccardo [8 ]
Briganti, Alberto [4 ]
Shariat, Shahrokh F. [9 ]
Schips, Luigi [7 ]
Karakiewicz, Pierre I. [1 ,3 ]
机构
[1] Univ Montreal, Hlth Ctr, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
[2] GD Annunzio Univ Chieti, SS Annunziata Hosp, Dept Urol, Chieti, Italy
[3] Univ Montreal, Hlth Ctr, Dept Urol, Montreal, PQ, Canada
[4] Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, URI, Unit Urol,Div Oncol, Milan, Italy
[5] Univ Hosp Hamburg Eppendorf, Martini Clin, Prostate Canc Ctr, Hamburg, Germany
[6] McMaster Univ, Div Urol, Hamilton, ON, Canada
[7] ASL, Dept Urol, Abruzzo 2, Chieti, Italy
[8] Virginia Commonwealth Univ Hlth Syst, Div Urol, Dept Surg, Richmond, VA USA
[9] Med Univ Vienna, Dept Urol, Vienna, Austria
关键词
Marital status; Renal cell carcinoma; Oncological outcomes; Gender; COLORECTAL-CANCER; SURVIVAL;
D O I
10.1007/s00345-017-2082-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose To examine the effect of marital status and gender on stage at diagnosis, tumor grade, treatment type and cancer specific mortality (CSM) in patients with localized renal cell carcinoma (RCC). Methods Within Surveillance, Epidemiology, and End Results registry (2001-2013), we identified 57,700 patients with T1-2 N-0 M-0 RCC. Logistic regression and competingrisks regression models tested the effect of marital status and gender on stage, tumor grade, treatment type and cancer specific mortality (CSM). Results Of all patients, 8.8, 10.6 and 14.8% were, respectively, widowed, separated/divorced and never married. The three categories accounted for 3.9, 9.0 and 14.9% of males (35,641) and for 16.7, 13.1 and 14.7% of females (22,059). Widowed (OR 1.13, p = 0.04), separated/divorced (OR 1.16, p = 0.02) and never married status (OR 1.38, p < 0.001) predisposed to higher rate of no surgical treatment. Widowed (HR 1.32, p < 0.001) and separated/divorced (HR 1.32, p < 0.001) status predisposed to higher CSM. Male gender predisposed to higher T-stage (OR 1.12, p < 0.001), higher tumor grade (OR 1.35, p < 0.001), no surgical treatment (OR 1.23, p < 0.001) and higher CSM (1.13, p = 0.01). Interaction tests between gender and marital status failed to reach independent predictor status in all analyses. Conclusions Male patients are at higher risk of less favorable baseline characteristics. Additionally, male, widowed and separated/divorced patients exhibit worse cancer control outcomes after treatment for T1-2 N-0 M-0 RCC. These observations indicate the need of more focused attention to those patients prior to, as well as after treatment for localized RCC.
引用
收藏
页码:1899 / 1905
页数:7
相关论文
共 28 条
  • [1] Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1–2 N0 M0 renal cell carcinoma
    Michele Marchioni
    Tristan Martel
    Marco Bandini
    Raisa S. Pompe
    Zhe Tian
    Anil Kapoor
    Luca Cindolo
    Riccardo Autorino
    Alberto Briganti
    Shahrokh F. Shariat
    Luigi Schips
    Pierre I. Karakiewicz
    World Journal of Urology, 2017, 35 : 1899 - 1905
  • [2] Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
    Georges Vlastos
    Isabel T. Rubio
    Nadeem Q. Mirza
    Lisa A. Newman
    Ravi Aurora
    Julie Alderfer
    Aman U. Buzdar
    S. Eva Singletary
    Annals of Surgical Oncology, 2000, 7 : 581 - 587
  • [3] Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
    Vlastos, G
    Rubio, IT
    Mirza, NQ
    Newman, LA
    Aurora, R
    Alderfer, J
    Buzdar, AU
    Singletary, SE
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (08) : 581 - 587
  • [4] Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas
    Attramadal, Cecilie Gjovaag
    Kumar, Sheeba
    Boysen, Morten E.
    Dhakal, Hari Prasad
    Nesland, Jahn Martin
    Bryne, Magne
    ANTICANCER RESEARCH, 2015, 35 (11) : 6111 - 6120
  • [5] Pre-operative Plateletcrit vs. Neutrophil to Lymphocyte Ratio in Predicting Biological Tumor Behavior in Patients with T1-4, N0, M0 Renal Cell Carcinoma: A Retrospective Analysis
    Surag, K. R.
    Choudhary, Anupam
    Singh, Anshuman
    Pm, Swathi
    Vishwanath, Kasi
    Rao, Mithun
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2024, 17 (01)
  • [6] Presentation and outcomes of patients with clinically T1-2, N0 oropharynx squamous cell carcinoma: The interplay of primary treatment modality and human papillomavirus status
    Al-Qurayshi, Zaid
    Zhu, Vivian L.
    Bayon, Rodrigo
    Buchakjian, Marisa R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (01): : 64 - 74
  • [7] Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer
    Kodama, Ken
    Higashiyama, Masahiko
    Okami, Jiro
    Tokunaga, Toshiteru
    Imamura, Fumio
    Nakayama, Tomio
    Inoue, Atsuo
    Kuriyama, Keiko
    ANNALS OF THORACIC SURGERY, 2016, 101 (02) : 504 - 511
  • [8] Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: A heterogeneous disease
    Hsu, Chung-Ping
    Hsia, Jiun-Yi
    Chang, Gee-Chen
    Chuang, Cheng-Yen
    Shai, Sen-Ei
    Yang, Shyh-Sheng
    Lee, Ming-Ching
    Kwan, Po-Cheung
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (02) : 426 - 433
  • [9] Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: A single-institution study
    Kodama, K
    Doi, O
    Higashiyama, M
    Yokouchi, H
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (03) : 347 - 353
  • [10] A Comparison of Stereotactic Radiation Therapy in Elderly Patients with Central or Peripheral Stage I-II (T1-3 N0 M0) Non-Small Cell Lung Cancer
    Ji, Xiaoqin
    Shi, Xuebing
    Hu, Jun
    Jiang, Wanrong
    Zhou, Bin
    Zhou, Houlong
    Yuan, Xi
    Li, Yikun
    Huang, Hua
    Wang, Jiasheng
    Ding, Wei
    Wang, Yong
    Sun, Xiangdong
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1557 - 1570